| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1089/HUM.2009.070 |
| P8608 | Fatcat ID | release_h22xzv57yfab3hrtyljfx6oayy |
| P698 | PubMed publication ID | 19848592 |
| P2093 | author name string | Barbara A Thorne | |
| Richard W Peluso | |||
| Ryan K Takeya | |||
| P2860 | cites work | Clonal growth of mammalian cells in vitro; growth characteristics of colonies from single HeLa cells with and without a feeder layer | Q36263015 |
| P433 | issue | 7 | |
| P304 | page(s) | 707-714 | |
| P577 | publication date | 2009-07-01 | |
| P1433 | published in | Human Gene Therapy | Q15757580 |
| P1476 | title | Manufacturing recombinant adeno-associated viral vectors from producer cell clones | |
| P478 | volume | 20 |
| Q59354464 | Accurate Titration of Infectious AAV Particles Requires Measurement of Biologically Active Vector Genomes and Suitable Controls |
| Q39409371 | Adeno-Associated Virus (AAV) as a Vector for Gene Therapy. |
| Q38789554 | Adeno-Associated Virus Gene Therapy for Liver Disease |
| Q64040883 | Adeno-associated virus vector as a platform for gene therapy delivery |
| Q36939744 | Advanced Characterization of DNA Molecules in rAAV Vector Preparations by Single-stranded Virus Next-generation Sequencing |
| Q41931475 | Advancements in the design and scalable production of viral gene transfer vectors. |
| Q39407680 | Analysis of particle content of recombinant adeno-associated virus serotype 8 vectors by ion-exchange chromatography. |
| Q38717682 | Characteristics of Minimally Oversized Adeno-Associated Virus Vectors Encoding Human Factor VIII Generated Using Producer Cell Lines and Triple Transfection |
| Q39674124 | Clearance and characterization of residual HSV DNA in recombinant adeno-associated virus produced by an HSV complementation system |
| Q34096401 | Dab2 attenuates brain injury in APP/PS1 mice via targeting transforming growth factor-beta/SMAD signaling |
| Q38903989 | MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain |
| Q26750799 | Manufacturing of recombinant adeno-associated viral vectors for clinical trials |
| Q38505122 | Manufacturing of recombinant adeno-associated viral vectors: new technologies are welcome |
| Q39126013 | Manufacturing of recombinant adeno-associated viruses using mammalian expression platforms |
| Q52717185 | Pharmacology of Recombinant Adeno-associated Virus Production. |
| Q39062624 | Production of adeno-associated virus (AAV) serotypes by transient transfection of HEK293 cell suspension cultures for gene delivery |
| Q36713761 | Progress and challenges in viral vector manufacturing |
| Q35819157 | Recombinant adeno-associated viral vector production and purification. |
| Q91259654 | Safety and efficacy evaluations of an adeno-associated virus variant for preparing IL10-secreting human neural stem cell-based therapeutics |
| Q33555259 | Scalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties |
| Q47551574 | Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes |
| Q37051728 | Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington's disease |
Search more.